Research ArticleOriginal Research

Respiratory Outcomes of Patients With Amyotrophic Lateral Sclerosis: An Italian Nationwide Survey

Michele Vitacca and Andrea Vianello
Respiratory Care September 2013, 58 (9) 1433-1441; DOI: https://doi.org/10.4187/respcare.02236

References

  1. 1.↵
    1. Strong M,
    2. Rosenfeld J
    . Amyotrophic lateral sclerosis: a review of current concepts. Amyotroph Lateral Scler Other Motor Neuron Disord 2003;4(3):136-143.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Raaphorst J,
    2. de Visser M,
    3. Linssen WH,
    4. de Haan RJ,
    5. Schmand B
    . The cognitive profile of amyotrophic lateral sclerosis: a. meta-analysis. Amyotroph Lateral Scler 2010;11(1-2):27-37.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Hadjikoutis S,
    2. Wiles CM
    . Respiratory complications related to bulbar dysfunction in motor neurone disease. Acta Neurol Scand 2001;103(4):207-2013.
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.
    1. Mustfa N,
    2. Moxham J
    . Respiratory muscle assessment in motor neurone disease. QJ Med 2001;94(9):497-502.
    OpenUrlFREE Full Text
  5. 5.↵
    1. Bach JR
    . Amyotrophic lateral sclerosis: prolongation of life by noninvasive respiratory aids. Chest 2002;122(1):92-98.
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    1. Moss AH,
    2. Oppenheimer EA,
    3. Casey P,
    4. Cazzolli PA,
    5. Roos RP,
    6. Stocking CB,
    7. Siegler M
    . Patients with amyotrophic lateral sclerosis receiving long-term mechanical ventilation: advance care planning and outcomes. Chest 1996;110(1):249-255.
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.
    1. Chiò A,
    2. Gauthier A,
    3. Calvo A,
    4. Ghiglione P,
    5. Mutani R
    . Caregiver burden and patients' perception of being a burden in ALS. Neurology 2005;64(10):1780-1782.
    OpenUrlCrossRef
  8. 8.↵
    1. Van Den Berg JP,
    2. Buskens E,
    3. Lindeman E,
    4. Van Den Berg LH
    . The costs of amyotrophic lateral sclerosis, according to type of care. Amyotroph Lateral Scler 2009;10(1):27-34.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Lyall RA,
    2. Donaldson D,
    3. Fleming T,
    4. Wood C,
    5. Newsom-Davis I,
    6. Polkey MI,
    7. et al
    . A prospective study of quality of life in ALS patients treated with noninvasive ventilation. Neurology 2001;57(1):153-156.
    OpenUrl
  10. 10.
    1. Bourke SC,
    2. Bullock RE,
    3. Williams TL,
    4. Shaw PJ,
    5. Gibson GJ
    . Noninvasive ventilation in ALS: indications and effect on quality of life. Neurology 2003;6(2):171-177.
    OpenUrl
  11. 11.↵
    1. Bourke SC,
    2. Tomlinson M,
    3. Williams TL,
    4. Bullock RE,
    5. Shaw PJ,
    6. Gibson GJ
    . Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol 2006;5(2):140-147.
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    1. Lo Coco D,
    2. Marchese S,
    3. La Bella V,
    4. Piccoli T,
    5. Lo Coco A
    . The amyotrophic lateral sclerosis functional rating scale predicts survival time in amyotrophic lateral sclerosis patients on invasive mechanical ventilation. Chest 2007;132(1):64-69.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Vianello A,
    2. Arcaro G,
    3. Palmieri A,
    4. Ermani M,
    5. Braccioni F,
    6. Gallan F,
    7. et al
    . Survival and quality of life after tracheostomy for acute respiratory failure in patients with amyotrophic lateral sclerosis. J Crit Care. 2011;26(3):329.e7-e14.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Miller RG,
    2. Jackson CE,
    3. Kasarskis EJ,
    4. England JD,
    5. Forshew D,
    6. Johnston W,
    7. et al
    . Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2009;73(15):1218-1226.
    OpenUrlCrossRef
  15. 15.↵
    1. McKim DA,
    2. Road J,
    3. Avendano M,
    4. Abdool S,
    5. Cote F,
    6. Duguid N,
    7. Fraser J,
    8. et al
    ; Canadian Thoracic Society Home Mechanical Ventilation Committee. Home mechanical ventilation: a Canadian Thoracic Society clinical practice guideline. Can Respir J 2011;18(4):197-215.
    OpenUrlPubMed
  16. 16.↵
    1. Melo J,
    2. Homma A,
    3. Iturriaga E,
    4. Frierson L,
    5. Amato A,
    6. Anzueto A,
    7. Jackson C
    . Pulmonary evaluation and prevalence of non-invasive ventilation in patients with amyotrophic lateral sclerosis: a multicenter survey and proposal of a pulmonary protocol. J Neurol Sci 1999;169(1-2):114-117.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    1. Bourke SC,
    2. Williams TL,
    3. Bullock RE,
    4. Gibson GJ,
    5. Shaw PJ
    . Noninvasive ventilation in motor neuron disease: current UK practice. Amotroph Lateral Scler Other Motor Neuron Disord 2002;3(3):145-149.
    OpenUrl
  18. 18.↵
    1. Ritsma BR,
    2. Berger MJ,
    3. Charland DA,
    4. Khoury MA,
    5. Phillips JT,
    6. Quon MJ,
    7. et al
    . NIPPV: prevalence, approach and barriers to use at Canadian ALS centers. Can J Neurol Sci 2010;37(1):54-60.
    OpenUrlPubMed
  19. 19.↵
    1. Lloyd-Owen SJ,
    2. Donaldson GC,
    3. Ambrosino N,
    4. Escarabill J,
    5. Farre R,
    6. Fauroux B,
    7. et al
    . Patterns of home mechanical ventilation use in Europe: results from the Eurovent survey. Eur Respir J 2005;25(6):1025-1031.
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    1. Robbins RA,
    2. Simmons Z,
    3. Bremer BA,
    4. Walsh SM,
    5. Fischer S
    . Quality of life in ALS is maintained as physical function declines. Neurology 2001;56(4):442-444.
    OpenUrlCrossRef
  21. 21.↵
    1. Kaub-Wittemer D,
    2. von Steinbuchel N,
    3. Wasner M,
    4. Laier-Groenveld G,
    5. Borasio GD
    . Quality of life and psychosocial issues in ventilated patients with amyotrophic lateral sclerosis and their caregivers. J Pain Symptom Manage 2003;26(4):890-896.
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    1. Suarez AA,
    2. Pessolano FA,
    3. Monteiro SG,
    4. Ferreyra G,
    5. Capria ME,
    6. Mesa L,
    7. et al
    . Peak flow and peak cough flow in the evaluation of expiratory muscle weakness and bulbar impairment in patients with neuromuscular diseases. Am J Phys Med Rehabil 2002;81(7):506-511.
    OpenUrlCrossRefPubMedWeb of Science
  23. 23.↵
    1. Chaudri MB,
    2. Liu C,
    3. Hubbard R,
    4. Jefferson D,
    5. Kinnear WJ
    . Relationship between supramaximal flow during cough and mortality in motor neurone disease. Eur Respir J 2002;19(3):434-438.
    OpenUrlAbstract/FREE Full Text
  24. 24.
    1. Sancho J,
    2. Servera E,
    3. Dıaz J,
    4. Marin J
    . Predictors of ineffective cough during a chest infection in patients with stable amyotrophic lateral sclerosis. Am J Respir Crit Care Med 2007;175(12):1266-1271.
    OpenUrlCrossRefPubMedWeb of Science
  25. 25.↵
    1. Hardiman O
    . Symptomatic treatment of respiratory and nutritional failure in amyotrophic lateral sclerosis. J Neurol 2000;247(4):245-251.
    OpenUrlCrossRefPubMedWeb of Science
  26. 26.↵
    National Institute for Health and Clinical Excellence. Understanding NICE guidance: information for people who use NHS services. Non-invasive ventilation for people with motor neurone disease. London: (CG105) National Institute for Health and Clinical Excellence; 2010.
  27. 27.↵
    1. Lyall RA,
    2. Donaldson N,
    3. Polkey MI,
    4. Leigh PN,
    5. Moxham J
    . Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis. Brain 2001;124(Pt10):2000-2013.
    OpenUrlAbstract/FREE Full Text
  28. 28.↵
    1. Miller RG,
    2. Rosenberg JA,
    3. Gelinas DF,
    4. Mitsumoto H,
    5. Newman D,
    6. Sufit R,
    7. et al
    . Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. Neurology 1999;52(7):1311-1323.
    OpenUrlCrossRef
  29. 29.↵
    1. Hull J,
    2. Aniapravan R,
    3. Chan E,
    4. Chatwin M,
    5. Forton J,
    6. Gallagher J,
    7. et al
    . British Thoracic Society guideline for respiratory management of children with neuromuscular weakness. Thorax 2012;67(Suppl 1):i1-i40.
    OpenUrlFREE Full Text
  30. 30.↵
    1. Mustfa N,
    2. Walsh E,
    3. Bryant V,
    4. Lyall RA,
    5. Addington-Hall J,
    6. Goldstein LH,
    7. et al
    . The effect of noninvasive ventilation on ALS patients and their caregivers. Neurology 2006;66(8):1211-1217.
    OpenUrlCrossRef
  31. 31.↵
    Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD, and nocturnal hypoventilation: a consensus conference report. Chest 1999;116(2):521-534.
    OpenUrlCrossRefPubMedWeb of Science
  32. 32.↵
    1. Perrin C,
    2. Unterborn JN,
    3. D'Ambrosio C,
    4. Hill NS
    . Pulmonary complications of chronic neuromuscular diseases and their management. Muscle Nerve 2004;29(1):5-27.
    OpenUrlCrossRefPubMedWeb of Science
  33. 33.↵
    1. Moss AH,
    2. Casey P,
    3. Stocking CB,
    4. Roos RP,
    5. Brooks BR,
    6. Siegler M
    . Home ventilation for amyotrophic lateral sclerosis patients: outcomes, costs and patient, family, and physician attitudes. Neurology 1993;43(2):438-443.
    OpenUrl
  34. 34.↵
    1. Borasio GD,
    2. Gelinas D,
    3. Yanagisawa N
    . Mechanical ventilation in amyotrophic lateral sclerosis: a cross-cultural perspective. J Neurol 1998;245(Suppl 2):S7-S12.
    OpenUrlCrossRef
  35. 35.↵
    1. Nava S,
    2. Sturani C,
    3. Hartl S,
    4. Magni G,
    5. Ciontu M,
    6. Corrado A
    . End-of-life decision-making in respiratory intermediate care units: a European survey. Eur Respir J 2007;30(1):156-164.
    OpenUrlAbstract/FREE Full Text
  36. 36.↵
    1. Oppenheimer EA
    . Amyotrophic lateral sclerosis. Eur Respir Rev 1992;2:323-329.
    OpenUrl
  37. 37.↵
    1. Bach JR,
    2. Bianchi C,
    3. Finder J,
    4. Fragasso T,
    5. Goncalves MR,
    6. Ishikawa Y,
    7. et al
    . Tracheostomy tubes are not needed for Duchenne muscular dystrophy. Eur Respir J 2007;30(1):179-180.
    OpenUrlFREE Full Text
  38. 38.↵
    1. Cazzolli PA,
    2. Brooks BR,
    3. Lewarski JL,
    4. McKim DA,
    5. Chatburn RL
    . Oral Secretion Scale (OSS) score in amyotrophic lateral sclerosis patients is associated with tolerance of non-invasive positive pressure ventilation, need for hospice or transition to tracheal positive pressure ventilation (TPPV) and survival (abstract). Amyotroph Lat Scler 2010;11(Suppl 1):140.
    OpenUrl
  39. 39.↵
    1. Van den Berg JP,
    2. Kalmijn S,
    3. Lindeman E,
    4. Veldink JH,
    5. de Visser M,
    6. Van der Graaff MM,
    7. et al
    . Multidisciplinary ALS care improves quality of life in patients with ALS. Neurology 2005;65(8):1264-1267.
    OpenUrlCrossRef
  40. 40.↵
    1. Andersen PM,
    2. Borasio GD,
    3. Dengler R,
    4. Hardiman O,
    5. Kollewe K,
    6. Leigh PN,
    7. et al
    . EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives. Eur J Neurol 2005;12(12):921-938.
    OpenUrlCrossRefPubMedWeb of Science
  41. 41.↵
    1. Chiò A,
    2. Calvo A,
    3. Moglia C,
    4. Gamna F,
    5. Mattei A,
    6. Mazzini L,
    7. Mora G
    . Non-invasive ventilation in amyotrophic lateral sclerosis: a 10 year population based study. J Neurol Neurosurg Psychiatry 2012;83(4):377-381.
    OpenUrlAbstract/FREE Full Text
Back to top

In this issue

 

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Related Articles

Cited By...

Keywords